Proteomics International Laboratories Ltd: Promarker technology used for diagnosing plant dieback
Proteomics International Laboratories Ltd: March 2024 Quarterly Activities Report and Appendix 4C
Proteomics International Laboratories Ltd: Investor presentation
Proteomics International Laboratories Ltd: Proteomics signs with Oxford Univ to validate test for Endo
Proteomics International Laboratories Ltd: PromarkerD US commercialisation & Promarker pipeline update
Proteomics International Laboratories Ltd: Proteomics International retains its ISO13485 certification
Proteomics International Laboratories Ltd: European patent granted for OxiDx technology
Proteomics International Laboratories Ltd: Interim Financial Report and Appendix 4D
Proteomics International Laboratories Ltd: Investor presentation - Euroz Hartleys Healthcare Forum
Proteomics International Laboratories Ltd: Study validates biomarkers for endometriosis blood test
Proteomics International Laboratories Ltd: Study validates biomarkers for oesophageal cancer blood test
Proteomics International Laboratories Ltd: Becoming a substantial holder
Proteomics International Laboratories Ltd: Investor Presentation
Proteomics International Laboratories Ltd: Change in substantial holding
Proteomics International Laboratories Ltd: Change of Director's Interest Notice
Proteomics International Laboratories Ltd: Application for quotation of securities - PIQ
Proteomics International Laboratories Ltd: Proposed issue of securities - PIQ
Proteomics International Laboratories Ltd: Cleansing prospectus
Proteomics International Laboratories Ltd: Proteomics to raise $6.5m through Institutional Placement
Proteomics International Laboratories Ltd: Proposed issue of securities - PIQ
No Data